Development of an antibody cocktail for treatment of Sudan virus infection
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development of an antibody cocktail for treatment of Sudan virus infection
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 117, Issue 7, Pages 3768-3778
Publisher
Proceedings of the National Academy of Sciences
Online
2020-02-04
DOI
10.1073/pnas.1914985117
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Two-Antibody Pan-Ebolavirus Cocktail Confers Broad Therapeutic Protection in Ferrets and Nonhuman Primates
- (2019) Zachary A. Bornholdt et al. Cell Host & Microbe
- Development of a Human Antibody Cocktail that Deploys Multiple Functions to Confer Pan-Ebolavirus Protection
- (2019) Anna Z. Wec et al. Cell Host & Microbe
- Post-exposure immunotherapy for two ebolaviruses and Marburg virus in nonhuman primates
- (2019) Jennifer M. Brannan et al. Nature Communications
- Structural basis of broad ebolavirus neutralization by a human survivor antibody
- (2019) Brandyn R. West et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Two Ebola treatments halve deaths in trial in DRC outbreak
- (2019) Owen Dyer BMJ-British Medical Journal
- Postexposure Protective Efficacy of T-705 (Favipiravir) Against Sudan Virus Infection in Guinea Pigs
- (2018) Md N Rahim et al. JOURNAL OF INFECTIOUS DISEASES
- Development of Clinical-Stage Human Monoclonal Antibodies That Treat Advanced Ebola Virus Disease in Nonhuman Primates
- (2018) Kristen E Pascal et al. JOURNAL OF INFECTIOUS DISEASES
- Post-Exposure Protection in Mice against Sudan Virus by a Two Antibody Cocktail
- (2018) Jeffrey Froude et al. Viruses-Basel
- The discovery of Bombali virus adds further support for bats as hosts of ebolaviruses
- (2018) Tracey Goldstein et al. Nature Microbiology
- Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial
- (2017) Feng-Cai Zhu et al. LANCET
- Chimpanzee Adenovirus Vector Ebola Vaccine
- (2017) Julie E. Ledgerwood et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Recombinant Vesicular Stomatitis Virus Ebola Vaccine
- (2017) Jason A. Regules et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe
- (2016) Selidji T. Agnandji et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection
- (2016) NEW ENGLAND JOURNAL OF MEDICINE
- A “Trojan horse” bispecific-antibody strategy for broad protection against ebolaviruses
- (2016) Anna Z. Wec et al. SCIENCE
- Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody
- (2016) D. Corti et al. SCIENCE
- Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak
- (2016) Z. A. Bornholdt et al. SCIENCE
- Rescue of non-human primates from advanced Sudan ebolavirus infection with lipid encapsulated siRNA
- (2016) Emily P. Thi et al. Nature Microbiology
- Interferon α/β Receptor–Deficient Mice as a Model for Ebola Virus Disease
- (2015) Jennifer M. Brannan et al. JOURNAL OF INFECTIOUS DISEASES
- The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial
- (2015) Angela Huttner et al. LANCET INFECTIOUS DISEASES
- Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp
- (2014) Xiangguo Qiu et al. NATURE
- Clinical Care of Two Patients with Ebola Virus Disease in the United States
- (2014) G. Marshall Lyon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Expression of Recombinant Antibodies
- (2013) André Frenzel et al. Frontiers in Immunology
- Virus nomenclature below the species level: a standardized nomenclature for natural variants of viruses assigned to the family Filoviridae
- (2012) Jens H. Kuhn et al. ARCHIVES OF VIROLOGY
- Protective Efficacy of Neutralizing Monoclonal Antibodies in a Nonhuman Primate Model of Ebola Hemorrhagic Fever
- (2012) Andrea Marzi et al. PLoS One
- Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease
- (2012) J. M. Dye et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques
- (2012) G. G. Olinger et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Successful Treatment of Ebola Virus-Infected Cynomolgus Macaques with Monoclonal Antibodies
- (2012) X. Qiu et al. Science Translational Medicine
- Characterization of Zaire ebolavirus glycoprotein-specific monoclonal antibodies
- (2011) Xiangguo Qiu et al. CLINICAL IMMUNOLOGY
- A shared structural solution for neutralizing ebolaviruses
- (2011) João M Dias et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- A Forward Genetic Strategy Reveals Destabilizing Mutations in the Ebolavirus Glycoprotein That Alter Its Protease Dependence during Cell Entry
- (2009) A. C. Wong et al. JOURNAL OF VIROLOGY
- Recombinant Vesicular Stomatitis Virus Vector Mediates Postexposure Protection against Sudan Ebola Hemorrhagic Fever in Nonhuman Primates
- (2008) T. W. Geisbert et al. JOURNAL OF VIROLOGY
- Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure
- (2008) Richard Strasser et al. PLANT BIOTECHNOLOGY JOURNAL
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started